Reversible cerebral atrophy: a case report and literature review.
Thirugnanasampanthan
Uma
U
Langley Porter Psychiatric Hospital and Clinics, University of California, San Francisco, San Francisco, CA 94143-0984, USA.
Foster
Adriana
A
Rauch
Ronald A
RA
D000927:Anticonvulsants / Q000008:administration & dosage / Q000009:adverse effects; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects; D001284:Atrophy; D001921:Brain / Q000473:pathology*; D001924:Brain Concussion / Q000150:complications* / Q000473:pathology*; D002552:Cerebral Ventricles / Q000473:pathology; D003693:Delirium / Q000150:complications / Q000473:pathology; D004359:Drug Therapy, Combination; D004565:Electroconvulsive Therapy; D005260:Female; D005500:Follow-Up Studies; D006220:Haloperidol / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D006801:Humans; D008875:Middle Aged; D012559:Schizophrenia / Q000188:drug therapy* / Q000473:pathology*; D014057:Tomography, X-Ray Computed; D014635:Valproic Acid / Q000008:administration & dosage / Q000009:adverse effects
D000927:Anticonvulsants; D014150:Antipsychotic Agents; D014635:Valproic Acid; C033563:haloperidol decanoate; D006220:Haloperidol